...
首页> 外文期刊>British Journal of Cancer >MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
【24h】

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker

机译:去势抵抗性前列腺癌的MicroRNA表达特征: microRNA-221 / 222 簇可作为抑癌和疾病进展的标志

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Our present study of the microRNA (miRNA) expression signature in castration-resistant prostate cancer (CRPC) revealed that the clustered miRNAs microRNA-221 ( miR-221 ) and microRNA-222 ( miR-222 ) are significantly downregulated in cancer tissues. The aim of this study was to investigate the functional roles of miR-221 and miR-222 in prostate cancer (PCa) cells. Methods: A CRPC miRNA signature was constructed by PCR-based array methods. Functional studies of differentially expressed miRNAs were analysed using PCa cells. The association between miRNA expression and overall survival was estimated by the Kaplan–Meier method. In silico database and genome-wide gene expression analyses were performed to identify molecular targets regulated by the miR-221/222 cluster. Results: miR-221 and miR-222 were significantly downregulated in PCa and CRPC specimens. Kaplan–Meier survival curves showed that low expression of miR-222 predicted a short duration of progression to CRPC. Restoration of miR-221 or miR-222 in cancer cells revealed that both miRNAs significantly inhibited cancer cell migration and invasion. Ecm29 was directly regulated by the miR-221/222 cluster in PCa cells. Conclusions: Loss of the tumour-suppressive miR-221/222 cluster enhanced migration and invasion in PCa cells. Our data describing targets regulated by the tumour-suppressive miR-221/222 cluster provide insights into the mechanisms of PCa and CRPC progression.
机译:背景:我们目前对去势抵抗性前列腺癌(CRPC)中microRNA(miRNA)表达特征的研究表明,在癌组织中成簇的miRNA microRNA-221(miR-221)和microRNA-222(miR-222)明显下调。 。这项研究的目的是研究miR-221和miR-222在前列腺癌(PCa)细胞中的功能。方法:通过基于PCR的阵列方法构建CRPC miRNA签名。使用PCa细胞分析了差异表达的miRNA的功能研究。通过Kaplan-Meier方法估计了miRNA表达与总生存之间的关联。在计算机数据库和全基因组范围内进行基因表达分析,以鉴定由miR-221 / 222簇调控的分子靶标。结果:PCa和CRPC标本中的miR-221和miR-222显着下调。 Kaplan–Meier生存曲线表明,miR-222的低表达预示了其向CRPC的发展持续时间很短。癌细胞中miR-221或miR-222的还原显示,两种miRNA均显着抑制癌细胞的迁移和侵袭。 Ecm29由PCa细胞中的miR-221 / 222簇直接调控。结论:肿瘤抑制性miR-221 / 222簇的丢失增强了PCa细胞的迁移和侵袭能力。我们的数据描述了由肿瘤抑制性miR-221 / 222簇调控的靶标,可深入了解PCa和CRPC进展的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号